Paul DiMarco introduces BioSpectra as your provider of critical small molecule excipients and APIs
BioSpectra exclusively manufactures GMP Excipients and APIs in our FDA registered facilities in the USA. Our emphasis is full GMP development for small-molecule synthesis and purification with a small volume emphasis and scale-up through commercial volumes. This includes full regulatory support up through and including USFDA Drug Master File submission.
To learn more about BioSpectra, please click here.
Video taken at AAPS, November 2018.